Related Experiment Video
Updated: May 13, 2025
06:32
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
Published on: May 2, 2025
152
PlateletBase: A Comprehensive Knowledgebase for Platelet Research and Disease Insights
Huaichao Luo1, Changchun Wu2, Sisi Yu3
1Department of Clinical Laboratory, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu 610041, China.
Genomics, Proteomics & Bioinformatics
|April 13, 2025
Summary
PlateletBase is a new comprehensive resource for platelet research, integrating genomic, transcriptomic, and proteomic data. It offers analytical tools to advance understanding of platelet function and related diseases.
Area of Science:
- Biomedical Informatics
- Molecular Biology
- Hematology
Background:
- Platelets play critical roles in numerous pathophysiological processes.
- A significant gap exists in comprehensive, dedicated resources for platelet research.
- Understanding platelet function is crucial for various disease mechanisms.
Purpose of the Study:
- To develop PlateletBase, a centralized knowledge base for platelet research.
- To enhance the study of platelets and associated diseases.
- To provide integrated data and analytical tools for platelet science.
Main Methods:
- Data retrieval from public databases, including the National Center of Biotechnology Information (NCBI).
- Analysis of RNA sequencing (RNA-seq) data from 3711 samples across 41 conditions.
- Development of six analytical and visualization tools for gene similarity, correlation, and annotation.
Main Results:
- PlateletBase integrates extensive data: 10,278 genomic, 31,758 transcriptomic, 4869 proteomic, and 2614 omics entries.
- Includes data on 1833 drugs, 97 platelet resources, and 438 diseases/traits.
- Features a user-friendly interface for data querying, manipulation, and analysis.
Conclusions:
- PlateletBase serves as a valuable, comprehensive resource for platelet research.
- Demonstrated utility in identifying diagnostic biomarkers and exploring disease mechanisms for conditions like gray platelet syndrome and angina pectoris.
- Facilitates advanced research into platelet functionality and related pathologies.
More Related Videos
Related Concept Videos
01:18Structure and Function of Platelets
891
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
891
01:22Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
396
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
396
01:16Clot Retraction and Fibrinolysis
2.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.9K
01:05Introduction to Hemostasis
4.5K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
4.5K